Tumefactive demyelinating lesions: Convetional and advanced magnetic resonance imaging

Multiple Sclerosis

Volumn 11, Issue 2, 2005, Pages 135-139

  Enzinger, Christian ^a   Strasser Fuchs, Siegrid ^a   Ropele, Stefan ^a   Kapeller, Peter ^a   Kleinert, Reinhold ^a   Fazekas, Franz ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Acute demyelination; Brain tumour; Demyelinating disease; MRI; MRS; MTR; Multiple sclerosis; Tumefactive lesion

Indexed keywords

ANTIBIOTIC AGENT; ANTIVIRUS AGENT; BETA1A INTERFERON; STEROID;

ADULT; ARTICLE; ASTROCYTOSIS; BRAIN BIOPSY; BRAIN TUMOR; CASE REPORT; CLINICAL FEATURE; CORRELATION FUNCTION; DEMYELINATING DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DRUG MEGADOSE; DYSPHASIA; EDEMA; FEMALE; FOLLOW UP; HEMIANOPIA; HUMAN; INFLAMMATION; JC VIRUS; MALE; MORBIDITY; NECROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; TUMEFACTIVE DEMYELINATING DISEASE; VERTIGO;

ACUTE DISEASE; ADULT; BRAIN NEOPLASMS; DEMYELINATING DISEASES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MULTIPLE SCLEROSIS; PROTONS;

EID: 15544364773     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1191/1352458505ms1145oa     Document Type: Article

References (14)

1. Kepes J. Large focal tumor-like demyelinating lesions of the brain: intermediate entity between multiple sclerosis and acute disseminated encephalomyelitis? A study of 31 patients. Ann Neurol 1993; 33: 18-27.
2. Mujic A, Liddell J, Hunn A, McArdle J, Beasley A. Non-neoplastic demyelinating process mimicking a disseminated malignant brain tumour. J Clin Neurosci 2002; 9: 313-17.
3. Butteriss DJ, Ismail A, Ellison DW, Birchall D. Use of serial proton magnetic resonance spectroscopy to differentiate low grade glioma from tumefactive plaque in a patient with multiple sclerosis. Br J Radiol 2003; 76: 662-65.
4. Annesley-Williams D, Farrell MA, Staunton H, Brett F. Acute demyelination, neuropathological diagnosis, and clinical evolution. J Neuropathol Exp Neurol 2000; 59: 477-89.
5. Cucurella MG, Rovira A, Grive E, Tintore M, Montalban X, Alonso J. Serial proton spectroscopy, magnetization transfer ratio and T2 relaxation in pseudotumoral demyelinating lesions. NMR Biomed 2002; 15: 284-92.
6. Ernst T, Chang L, Walot I, Huff K. Physiologic MRI of a tumefactive multiple sclerosis lesion. Neurology 1998; 51: 1486-88.
7. Saindane AM, Cha S, Law M, Xue X, Knopp EA, Zagzag D. Proton MR spectroscopy of tumefactive demyelinating lesions. Am J Neuroradiol 2002; 23: 1378-86.
8. Masdeu JC, Quinto C, Olivera C, Tenner M, Leslie D, Visintainer P. Open-ring imaging sign: highly specific for atypical brain demyelination. Neurology 2000; 11: 1427-33.
9. Lucchinetti C, Brück W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 2000; 47: 707-17.
10. Bruck W, Neubert K, Berger T, Weber JR. Clinical, radiological, immunological and pathological findings in inflammatory CNS demyelination-possible markers for an antibody-mediated process. Mult Scler 2001; 7: 173-77.
11. Kurki T, Lundbom N, Kalimo H, Valtonen S. MR classification of brain gliomas: value of magnetization transfer and conventional imaging. Magn Reson Imaging 1995; 13: 501-11.
12. Pui M. Magnetization transfer analysis of brain tumor, infection, and infarction. J Magn Reson Imaging 2000; 12: 395-99.
13. Mehta RC, Pike GB, Enzmann DR. Measure of magnetization transfer in multiple sclerosis demyelinating plaques, white matter ischemic lesions, and edema. Am J Neuroradiol 1996; 17: 1051-55.
14. Castriota-Scanderbeg A, Sabatini U, Fasano F, Floris R, Fraracci L, Mario MD et al. Diffusion of water in large demyelinating lesions: a follow-up study. Neuroradiology 2002; 44: 764-67.